JeNaCell
Latest round
- Series A
Last raised
- Jul 2015
Total raised
- $0.9M
Investors
- 5
About JeNaCell
Based in Thüringen, Germany, and co-founded by Dana Kralisch (CEO) in 2012, as a spin-off from the Friedrich Schiller University of Jena in Germany, JeNaCell GmbH operates as a biotechnology company specializing in bio-material with natural nanostructures. In August 2021, the firm was acquired by Evonik Industries AG from High-Tech Gründerfonds, STIFT, bm-t beteiligungsmanagement Thüringen, and Sparkasse Jena. The company develops and produces products using biosynthetic cellulose, a nature-inspired material with bioengineered architecture generated by bacteria, to support customers in medical devices, wound care, and advanced dermatology. JeNaCell's product portfolio includes brands like BIOCELLIC®, a soft, flexible, moist, and cool base material, produced from sugar using a biotechnological fermentation process for custom developments, EPI NOUVELLE®, a skin-friendly biomaterial made from vegetable raw materials, and EPICITE® BALANCE, a wound dressing for the treatment of chronic and slow healing wounds.
Who invested in JeNaCell
5 investors across 2 rounds
See all investors in JeNaCell
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about JeNaCell
Who invested in JeNaCell?
JeNaCell has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has JeNaCell raised?
JeNaCell has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did JeNaCell last raise money?
JeNaCell's most recent round on record is a Series A, in Jul 2015.
What does JeNaCell do?
Based in Thüringen, Germany, and co-founded by Dana Kralisch (CEO) in 2012, as a spin-off from the Friedrich Schiller University of Jena in Germany, JeNaCell GmbH operates as a biotechnology company specializing in bio-material with natural nanostructures.
Where is JeNaCell headquartered?
JeNaCell is headquartered in Jena, Germany.
Which VCs invest in companies like JeNaCell?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at JeNaCell's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like JeNaCell? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.